SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

Never Miss a Story

Sign Up For Weekly Top Stories

 

More Industry Headlines

Blue Cross Blue Shield plans ACA exits in two states Will pull out of three markets in Tennessee and Nebraska in 2017

GE will invest $50 million into disruptive health care startups worldwide Launches accelerator five.eight to move the needle on global care

Roughly half of radiotherapy candidates in developing countries lack access: ASTRO It's a 'give a man a fish' problem

NSF awards grant to develop MR-guided robotic biopsies Guidabot designed for real-time imaging of minimally invasive neurological interventions

P-Cure showcases seated position imaging solution for proton therapy at ASTRO Could be beneficial for treating upper body indications

Boston Scientific to acquire EndoChoice for $210 million Expanding endoscopy presence as pacemakers and implanted defibrillator sales slow

SBRT studies show positive results for lung cancer in elderly and prostate cancer New research unveiled at ASTRO

New radiation therapy techniques boost early stage lung cancer survival rates: ASTRO

The ASTRO new product showcase A few products and companies that will be featured at this year's premiere oncology meeting

Stereotactic radiosurgery vs. whole brain radiation therapy: study compares outcomes at ASTRO

IBA spin-off, Novation ink PET radiopharmaceutical deal

by Brendon Nafziger , DOTmed News Associate Editor
Ion Beam Applications S.A.'s newly spun-off radiopharmaceutical wing IBA Molecular has inked a five-year deal with group purchasing organization Novation LLC to supply its member health care facilities with PET radiotracers.

Under the deal, announced Monday, IBA Molecular will supply imaging agents, including 18-Fluorodeoxyglucose, as well as provide educational and training services. The contract took effect July 1. Terms of the deal weren't disclosed.

Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material, camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED



IBA Molecular has 54 PET isotope facilities in Europe, North America and Asia. It also delivers agents for SPECT imaging worldwide.

SK Capital Partners holds a controlling stake in IBA Molecular, which was spun off from its Belgian parent company, which retains a minority stake, in April.

Related:


Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.

You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2016 DOTmed.com, Inc.
ALL RIGHTS RESERVED